Most people who develop COVID-19 after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection present with paucisymptomatic and non-severe disease. However, approximately 20% of patients develop severe COVID-19 requiring hospitalisation, including 5% who are admitted to the intensive care unit (ICU). The ongoing COVID-19 outbreak has led to an unprecedented health crisis. Hence, it is crucial to identify individuals who are susceptible to developing severe COVID-19 and cou...

Moderna Inc’s (MRNA.O) experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday.



The data comes from eight people who took part in a 45-subject safety trial that kicked off in March. The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more...

Sony AI Inc and avatarin Inc, an ANA Group company, have reached a basic agreement to work together to develop next-generation remote control robots by combining the AI and robotics technology of Sony AI with avatarin's avatar (remote control robot) technology.

Next-generation avatar robots are expected to play a central role in situations where autonomous robots have barriers to safe and cost effective deployment, and where it is difficult for people to perform physical tasks. Alo...

Sony AI Inc and avatarin Inc, an ANA Group company, have reached a basic agreement to work together to develop next-generation remote control robots by combining the AI and robotics technology of Sony AI with avatarin's avatar (remote control robot) technology.

Next-generation avatar robots are expected to play a central role in situations where autonomous robots have barriers to safe and cost effective deployment, and where it is difficult for people to perform physical tasks. Alo...

Researchers at King’s College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. Their findings were published on May 11, 2020, in Nature Medicine.

The AI model uses data from the COVID Symptom Study app to predict COVID-19 infection, by comparing people’s symptoms and the results of traditional COVID tests. Researchers say thi...

As the novel coronavirus spread rapidly across the United States this March, testing was lacking. While there were many problems, one simple one was a lack of test swabs. These nasopharyngeal swabs go into patients’ noses to grab a sample to test. To scale up testing, the country needed tens of millions—or perhaps hundreds of millions—of them. One major solution emerged: 3D printing. In this video, we look at how the country’s biggest 3D printing companies rushed to design and manufacture...

A 21-year-old Somali mechanical engineer has invented a homemade respirator to try to help his country during the COVID-19 Pandemic.

The east African nation is suffering from a severe lack of respiratory equipment, which concerned Mogadishu-based Mohamad Adawe.

Previously, medical staff in Somalia have mainly had to assist patients' breathing by manually pumping the equipment. This has also brought them into close contact with the infected people, heightening the risk of con...

Lately, there’s been much buzz in the news about an unorthodox way of finding a vaccine for COVID-19: human challenge trials. Whereas plenty of articles have debated whether human challenge trials should be legal, this article focuses on whether we have a moral duty to participate in them. The goal here isn’t to single-handedly answer this complex moral question, but rather to provide two frameworks we can use to help us arrive at our own answers.

What exactly is a human challenge ...

Global health care is experiencing an unprecedented surge in the number of critically ill patients who require mechanical ventilation due to the COVID-19 pandemic. The requirement for relatively long periods of ventilation in those who survive means that many are considered for tracheostomy to free patients from ventilatory support and maximise scarce resources. COVID-19 provides unique challenges for tracheostomy care: health-care workers need to safely undertake tracheostomy procedures and ...

Abstract"A novel coronavirus was recently discovered and termed SARS-CoV-2. Human infection can cause coronavirus disease 2019 (COVID-19), which has been rapidly spreading around the globe. SARS-CoV-2 shows some similarities to other coronaviruses. However, treatment options and a cellular understanding of SARS-CoV-2 infection are lacking. Here we identify the host cell pathways modulated by SARS-CoV-2 infection and show that inhibition of these pathways prevent viral replication in human cel...

The COVID‐19 pandemic has disrupted routine hospital services globally. This study estimated the total number of adult elective operations that would be cancelled worldwide during the 12 weeks of peak disruption due to COVID‐19.

A global expert‐response study was conducted to elicit projections for the proportion of elective surgery that would be cancelled or postponed during the 12 weeks of peak disruption. A Bayesian beta‐regression model was used to estimate 12‐week cancellation rat...

As hospitals are preparing for the resumption of elective surgery, research shows that patients have many questions and specific uncertainties about the safety of undergoing elective operations in hospitals, regardless of whether COVID-19 patients are being concurrently treated in the same facility.
Patients are increasingly requesting information about their facility's readiness for safely performing surgery, and they trust their surgeon to deliver safe and high-quality ca...